| VARIABLE | ABO-MATCHED | ABO-MISMATCHED | SIG. |
|---|---|---|---|
| (n = 78) | (n = 34) | ||
| Age | 52 (+/− 13) | 47 (+/−16) | 0.1 |
| Sex | |||
| -Male | 49 (62.8) | 22 (64.7) | 0.85 |
| -Female | 29 (37.2) | 12 (35.3) | |
| Baseline disease | |||
| -AML | 41 (52.6) | 9 (26.5) | |
| -ALL | 5 (6.4) | 1 (2.9) | 0.036 |
| -Lymphoma | 18 (23.1) | 12 (35.3) | |
| -Other | 14 (17.9) | 12 (35.3) | |
| Conditioning | |||
| -MA | 25 (33.8) | 12 (35.3) | 0.4 |
| -RIC | 49 (66.2) | 22 (64.7) | |
| -RIC (sequential) | 4 (5.1) | 0 (0) | |
| GVHD prophylaxis | |||
| Cyclophosphamide | 73 (96.1) | 30 (88.2) | 0.19 |
| -ATG | 4 (5.1) | 2 (5.9) | 1 |
| Number of infused cells (x106/Kg) | 6.11 (1.4) | 5.68 (1.2) | 0.14 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.